SynthesisImmunity, inflammation and disease2022

Artesunate, imatinib, and infliximab in COVID-19: A rapid review and meta-analysis of current evidence.

Bahman Amani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.